AP9700940A0 - Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring - Google Patents

Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring

Info

Publication number
AP9700940A0
AP9700940A0 AP9700940A AP9700940A AP9700940A0 AP 9700940 A0 AP9700940 A0 AP 9700940A0 AP 9700940 A AP9700940 A AP 9700940A AP 9700940 A AP9700940 A AP 9700940A AP 9700940 A0 AP9700940 A0 AP 9700940A0
Authority
AP
ARIPO
Prior art keywords
carbocyclic ring
base attached
nucleoside analogues
substituted benzimidazole
antiviral nucleoside
Prior art date
Application number
AP9700940A
Other versions
AP741A (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/304,006 external-priority patent/US5534535A/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of AP9700940A0 publication Critical patent/AP9700940A0/en
Application granted granted Critical
Publication of AP741A publication Critical patent/AP741A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
APAP/P/1997/000940A 1994-09-09 1995-09-11 Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring. AP741A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/304,006 US5534535A (en) 1992-03-09 1994-09-09 Therapeutic nucleosides
PCT/US1995/011366 WO1996007646A1 (en) 1994-09-09 1995-09-11 Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring

Publications (2)

Publication Number Publication Date
AP9700940A0 true AP9700940A0 (en) 1997-04-30
AP741A AP741A (en) 1999-04-26

Family

ID=23174626

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1997/000940A AP741A (en) 1994-09-09 1995-09-11 Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring.

Country Status (17)

Country Link
EP (1) EP0779885A1 (en)
JP (1) JPH10505092A (en)
CN (1) CN1164855A (en)
AP (1) AP741A (en)
AU (1) AU3692895A (en)
BR (1) BR9508826A (en)
CA (1) CA2199502A1 (en)
CZ (1) CZ71297A3 (en)
FI (1) FI970959A7 (en)
HU (1) HUT77440A (en)
IS (1) IS4436A (en)
NO (1) NO971070L (en)
NZ (1) NZ294095A (en)
OA (1) OA10601A (en)
PL (1) PL319440A1 (en)
SK (1) SK29197A3 (en)
WO (1) WO1996007646A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912356A (en) * 1995-09-11 1999-06-15 Glaxo Wellcome Inc. Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring
GB9600142D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Chemical compounds
CA2280761A1 (en) 1997-02-13 1998-08-20 Stanley Dawes Chamberlain Benzimidazole derivatives
NZ502882A (en) 1997-07-30 2002-02-01 Glaxo Group Ltd Lyxofuranosyl benzimidazoles as antiviral agents
US6770666B2 (en) 1999-12-27 2004-08-03 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs
NZ514403A (en) 1999-12-27 2002-10-25 Japan Tobacco Inc Fused-ring compounds and use thereof as drugs
GB0008939D0 (en) 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
AR035543A1 (en) * 2001-06-26 2004-06-16 Japan Tobacco Inc THERAPEUTIC AGENT FOR HEPATITIS C THAT INCLUDES A CONDENSED RING COMPOUND, CONDENSED RING COMPOUND, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS, BENZIMIDAZOL, THIAZOL AND BIFENYL COMPOUNDS USED AS INTERMEDIARY COMPARTMENTS OF COMPARTMENTS
CN1834090B (en) * 2005-03-18 2011-06-29 中国科学院上海药物研究所 Benzimidazole compound, its preparation method and use
WO2009042013A1 (en) 2007-08-02 2009-04-02 Millennium Pharmaceuticals, Inc. Process for the synthesis of e1 activating enzyme inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9205071D0 (en) * 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides

Also Published As

Publication number Publication date
FI970959A7 (en) 1997-05-06
IS4436A (en) 1997-03-07
AU3692895A (en) 1996-03-27
CA2199502A1 (en) 1996-03-14
OA10601A (en) 2002-09-03
BR9508826A (en) 1997-09-30
JPH10505092A (en) 1998-05-19
WO1996007646A1 (en) 1996-03-14
EP0779885A1 (en) 1997-06-25
NZ294095A (en) 1998-08-26
CN1164855A (en) 1997-11-12
AP741A (en) 1999-04-26
CZ71297A3 (en) 1997-08-13
PL319440A1 (en) 1997-08-04
NO971070L (en) 1997-05-07
NO971070D0 (en) 1997-03-07
HUT77440A (en) 1998-04-28
MX9701789A (en) 1997-10-31
SK29197A3 (en) 1997-10-08
FI970959A0 (en) 1997-03-06

Similar Documents

Publication Publication Date Title
FI935114A7 (en) Backbone-modified oligonucleotide analogs
PH24388A (en) Antiviral nucleosides
IL113432A0 (en) Diastereoselective synthesis of nucleoside analogues
FI902386A7 (en) Nucleoside analogues
IL98918A0 (en) Carbocyclic analogs of certain nucleosides
FI944134L (en) Antiviral nucleoside analogues
IL99466A0 (en) Noel carbocyclic adenosine analogs useful as immunosuppressants
AP9700940A0 (en) Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring
PH27609A (en) Antiviral agents
ZA876673B (en) Nucleoside analogues
IL143867A0 (en) Antiviral nucleoside analogues
GB8827337D0 (en) Nucleoside analogues
EP0450065A4 (en) Antiviral agent
GB2184944B (en) Antiviral agents
ZA861933B (en) Antiviral nucleosides
EP0243192A3 (en) Antiviral 8-phenylxanthines
AU4378589A (en) Carbocyclic nucleoside analogs
FI961105L (en) Difluorostatin antiviral analogues
IE893412L (en) Carbocyclic nucleoside analogues
ZA917151B (en) Carbocyclic nucleoside analogs useful as immunosuppressants
CY2006A (en) Antiviral combinations containing nucleoside analogs
ZA917152B (en) Novel carbocyclic adenosine analogs useful as immunosuppressants
GB9222203D0 (en) Nucleoside analogues
GB8816117D0 (en) Antiviral nucleosides
GB9110081D0 (en) Nucleoside analogues